Gene · 923
Papers1,942
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,942
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Honeycomb-like Structured Film, a Novel Therapeutic Device, Suppresses Tumor Growth in an In Vivo Ovarian Cancer Model. | Cancers (Basel) | 2022 | 36612230 | PubTator, text mining | PubMed |
| Nipah Virus Disease: Epidemiological, Clinical, Diagnostic and Legislative Aspects of This Unpredictable Emerging Zoonosis. | Animals (Basel) | 2022 | 36611767 | PubTator, text mining | PubMed |
| Spinal subarachnoid hemorrhage after percutaneous kyphoplasty: a case report and literature review. | J Spine Surg | 2022 | 36605992 | PubTator, text mining | PubMed |
| STATUS OF THE CELLULAR IMMUNITY IN CLEAN-UP WORKERS OF THE CHORNOBYL ACCIDENT AND PATIENTS WITH CANCER OF THE MOUTH CAVITY, ORAL AND LARYNGEAL PART OF THE PHARYNX. | Probl Radiac Med Radiobiol | 2022 | 36582098 | PubTator, text mining | PubMed |
| Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer. | Eur J Med Res | 2022 | 36581948 | PubTator, text mining | PubMed |
| A novel technology for home monitoring of lupus nephritis that tracks the pathogenic urine biomarker ALCAM. | Front Immunol | 2022 | 36569940 | PubTator, text mining | PubMed |
| A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis. | iScience | 2022 | 36561889 | PubTator, text mining | PubMed |
| Markers of Bronchiolitis Obliterans Syndrome after Lung Transplant: Between Old Knowledge and Future Perspective. | Biomedicines | 2022 | 36552035 | PubTator, text mining | PubMed |
| An Efficient AP-ANN-Based Multimethod Fusion Model to Detect Stress through EEG Signal Analysis. | Comput Intell Neurosci | 2022 | 36544857 | PubTator, text mining | PubMed |
| Adverse drug reactions of itolizumab in COVID-19 patient: A case report. | Indian J Pharmacol | 2022 | 36537408 | PubTator, text mining | PubMed |
| Recruited monocytes/macrophages drive pulmonary neutrophilic inflammation and irreversible lung tissue remodeling in cystic fibrosis. | Cell Rep | 2022 | 36516754 | PubTator, text mining | PubMed |
| Dysfunctional intercellular communication and metabolic signaling pathways in thin endometrium. | Front Physiol | 2022 | 36505055 | PubTator, text mining | PubMed |
| Replacing the Burden of the Gluten Free Diet: Then, Now, and the Future. | Int J Mol Sci | 2022 | 36499446 | PubTator, text mining | PubMed |
| The Enigmatic Nature of the TCR-pMHC Interaction: Implications for CAR-T and TCR-T Engineering. | Int J Mol Sci | 2022 | 36499057 | PubTator, text mining | PubMed |
| IL-17A and TNF-α inhibitors induce multiple molecular changes in psoriasis. | Front Immunol | 2022 | 36483564 | PubTator, text mining | PubMed |
| Comparative glycoproteomics study on the surface of SKOV3 versus IOSE80 cell lines. | Front Chem | 2022 | 36482940 | PubTator, text mining | PubMed |
| Attenuated inflammatory profile following single and repeated handgrip exercise and remote ischemic preconditioning in patients with cerebral small vessel disease. | Front Physiol | 2022 | 36479354 | PubTator, text mining | PubMed |
| Significance of monocyte infiltration in patients with gastric cancer: A combined study based on single cell sequencing and TCGA. | Front Oncol | 2022 | 36479092 | PubTator, text mining | PubMed |
| Phase 2 trial of intravenous oncolytic virus JX-594 combined with low-dose cyclophosphamide in patients with advanced breast cancer. | Exp Hematol Oncol | 2022 | 36474303 | PubTator, text mining | PubMed |
| The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic. | Polym Bull (Berl) | 2022 | 36466080 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/923/papers?page=18